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Background: Manual eligibility screening (ES) for a clinical trial typically requires a labor-intensive review of patient
records that utilizes many resources. Leveraging state-of-the-art natural language processing (NLP) and information
extraction (IE) technologies, we sought to improve the efficiency of physician decision-making in clinical trial enrollment.
In order to markedly reduce the pool of potential candidates for staff screening, we developed an automated ES
algorithm to identify patients who meet core eligibility characteristics of an oncology clinical trial.
Methods: We collected narrative eligibility criteria from ClinicalTrials.gov for 55 clinical trials actively enrolling oncology
patients in our institution between 12/01/2009 and 10/31/2011. In parallel, our ES algorithm extracted clinical and
demographic information from the Electronic Health Record (EHR) data fields to represent profiles of all 215 oncology
patients admitted to cancer treatment during the same period. The automated ES algorithm then matched the trial
criteria with the patient profiles to identify potential trial-patient matches. Matching performance was validated on a
reference set of 169 historical trial-patient enrollment decisions, and workload, precision, recall, negative predictive
value (NPV) and specificity were calculated.
Results: Without automation, an oncologist would need to review 163 patients per trial on average to replicate the
historical patient enrollment for each trial. This workload is reduced by 85% to 24 patients when using automated ES
(precision/recall/NPV/specificity: 12.6%/100.0%/100.0%/89.9%). Without automation, an oncologist would need to
review 42 trials per patient on average to replicate the patient-trial matches that occur in the retrospective data set.
With automated ES this workload is reduced by 90% to four trials (precision/recall/NPV/specificity: 35.7%/100.0%/
100.0%/95.5%).
Conclusion: By leveraging NLP and IE technologies, automated ES could dramatically increase the trial screening
efficiency of oncologists and enable participation of small practices, which are often left out from trial enrollment. The
algorithm has the potential to significantly reduce the effort to execute clinical research at a point in time when new
initiatives of the cancer care community intend to greatly expand both the access to trials and the number of available
trials.
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Although several reports have described positive experi-
ences leveraging electronic health record (EHR) infor-
mation to facilitate trial recruitment, eligibility screening
(ES) is still conducted manually in most cases [1-3].
Manual ES typically requires a lengthy review of patient
records and trial criteria descriptions, a cumbersome
process that creates a significant financial burden for an
institution [4]. The clinical trial phase is the most expen-
sive component of drug development; therefore, any
improvement in the efficiency of the recruitment process
should be highly consequential [5]. The factor that most
clinical practices are not staffed for manual patient
screening is also a challenge for clinical trial recruitment.
For these reasons, automatically prescreening and identi-
fying trial-patient matches, on the basis of EHR informa-
tion, promises great benefits for translational research.
Several informatics tools have been described in the
literature to automate trial-patient matching [6-19].
There are two approaches to matching patients and tri-
als: 1) identifying a cohort of patients for a particular
trial; and 2) identifying clinical trials for an individual
patient. In this study, we refer to the first use case as
trial-centered patient cohort identification and the sec-
ond as patient-centered trial recommendation. Recent
studies mainly focus on the first approach because they
usually target a small set of clinical trials [6,7,10-12,15-17].
Nevertheless, patient-centered trial recommendation is
also valuable, particularly if the key barrier to physician
participation is the time required for identifying appropri-
ate trials for individual patients from a large pool of active
trials [18].
Despite these previous efforts, many barriers remain for
automated ES [20,21]. Early studies were dedicated to
matching trial eligibility criteria with structured and semi-
structured EHR data (e.g. demographics, ICD-9 codes and
laboratory results) [6,7,9,15]. However, the logic-based
triggers usually require manual design. Automatically gen-
erating computable triggers from narrative eligibility criteria
remains challenging [22]. On the other hand, since a sub-
stantial portion of meaningful information in the EHR is
represented only in narrative text, progress in natural
language processing (NLP) and information extraction (IE),
can enhance the accuracy of trial-patient matching [21,23].
Relevant NLP and IE techniques have been summarized
and reported in the annual Text Retrieval Conference
(TREC) medical record track [21,24-30]. However, only a
handful of the techniques were evaluated on real-world
trial-patient matching, and most of them focused on one
clinical trial [10-12,14,16]. Even the TREC medical record
track, because of the lack of available real-world trial-
patient matches, had to use synthetic clinical queries to
evaluate ES algorithms. Additional study of the algorithms
is therefore required to address the gap in evaluation.We implemented and developed an automated ES
algorithm in our earlier pediatric Emergency Depart-
ment (ED) study [17]. The algorithm consisted of three
core components: 1) a logic-based filter that excluded
patients based on EHR structured data fields, 2) an NLP-
based concept detector that identified keywords and med-
ical terms from narrative eligibility criteria and patient
clinical notes, and 3) an IE-based trial-patient matching
function that computed the degree of match between trial
criteria and patient clinical information (see “Automated
ES algorithm” for detailed implementation). The algo-
rithm has been evaluated retrospectively on all clinical
trials that recruited patients with specific diagnoses in our
ED during the study period, and it showed promising per-
formance in trial-centered patient cohort identification
[17]. The objective of the current study is to validate the
generalizability of the ES algorithm on real-word pediatric
oncology clinical trials and EHR data, where the specific
aim is to identify patients who meet core eligibility charac-
teristics for cancer trials. Due to the large number of trials
available to a pediatric oncology patient, patient-centered
trial recommendation becomes important in oncology
trial recruitment [18]. Therefore, in this study we evaluate
the proposed algorithm on both trial-centered and
patient-centered scenarios.
Methods
The study population consisted of all pediatric oncology
patients admitted at Cincinnati Children’s Hospital Medical
Center (CCHMC) between December 2009 and October
2011. Approval of ethics for this study was given by the
CCHMC institutional review board (study ID: 2010–3031)
and a waiver of consent was authorized.
Clinical trials and data
Eligibility criteria descriptions of clinical trials
We composed a comprehensive list of the 70 oncology
trials, which enrolled patients at CCHMC during the
study period. To be more conservative in the evaluation
of the ES algorithm, we excluded all repository trials,
which customarily enrolled all patients, and the institu-
tional trials for which we did not find the trial announce-
ments on ClinicalTrials.gov. This process resulted in a set
of 55 trials for the current study.
To obtain the narrative eligibility criteria of the trials,
we searched their NCT identifiers on ClinicalTrials.gov
and downloaded the corresponding inclusion and exclu-
sion sections. The list of the trials including NCT identi-
fiers, number of enrolled patients during the study
period, opening and closing dates, and special circum-
stances in enrollment are presented in (Additional file 1:
Table S1). Figure 1 shows an example eligibility criteria
section. Compared with the clinical trials used in our
earlier study [17], the criteria of oncology trials were
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terms and acronyms (Figure 1). In addition, two demo-
graphic attributes, age and gender, were retrieved from
the eligibility criteria via NLP techniques.Patient EHR data
During the study period 215 CCHMC patients partici-
pated in cancer treatment and all of them were included
in our study. Based on the trials’ criteria, we extracted
the demographics (age and gender), diagnoses and asso-
ciated ICD-9 codes from structured EHR data, and un-
structured clinical notes to represent the patients’
profiles. Figure 2 shows the frequencies of the collected
EHR data fields and the descriptive statistics of the clin-
ical notes. The structured diagnoses and ICD-9 codes
contained precise information about the patients’ clinical
problems, while the unstructured clinical notes provided
more comprehensive information including symptoms
and disease progression. Compared with the ED patients
investigated in our earlier study [17], the pediatric oncol-
ogy patients had more diagnoses and clinical notes.
Because some of the diagnoses and notes were entered
in the EHR after the end of a trial’s enrollment period,
when automating the ES for that trial, we excluded them
if they had an EHR entry-timestamp after the trial's clos-
ing date. Furthermore, if his/her physician enrolled a
patient in a trial, we only used the diagnoses and notesFigure 1 An example eligibility description (NCT01154816) derived from Cwritten before the patient’s enrollment date in that par-
ticular trial. The information collected until that point
represented the information that was available to the
physician at the time of making the enrollment decision.Historical trial-patient enrollment decisions
One hundred and twenty seven patients were enrolled in
one or more of the 55 trials, providing us with 169
patient-trial matches as a reference standard. Unlike for
adult clinical trials, the enrollment of pediatric oncology
patients is almost universal. Almost all eligible patients
accept trial invitations. The National Cancer Institute
(NCI) bulletin shows that more than 90% of pediatric
oncology patients younger than five participate in trials
[31]. The enrollment rate is lower in adolescents but it is
still a magnitude higher than in adults.
The special circumstances of pediatric oncology trial
screening have two important consequences. First, al-
though the historical enrollment decisions do not build
a traditional gold standard because they were not made
as part of a controlled double chart review process (e.g.,
inter-screener agreement is not available); they produce
a useful reference standard to evaluate the ES algorithm
because the decision making covers the entire study
population. Second, because of the high enrollment rate
specific for the study population, to determine the
generalizability of conclusions drawn from testing thelinicalTrials.gov.
Number of tokens** Number of patientsNumber of notes
DC - Discharge
E D- Emergency department
H&P- History and physical
OPTP- Oncology program treatment plan
OR- Operating room




Total Number of Data Entries* Average Number of Entries per Patient
(a)
(b)
Figure 2 Frequencies of the collected EHR fields (a) and descriptive statistics of the unstructured clinical notes (b). *A data entry is a piece of
information (e.g. diagnosis) documented during a patient’s visit. If a patient has the same diagnosis/ICD-9 code during multiple visits, we only
count the diagnosis/ICD-9 code once for that patient. **Tokens include words, numbers, symbols and punctuations in clinical narratives.
Ni et al. BMC Medical Informatics and Decision Making  (2015) 15:28 Page 4 of 10algorithm on retrospective pediatric oncology trial en-
rollment decisions will require additional research.
Automated ES algorithm
We customized and implemented state-of-the-art NLP
and IE techniques to build the automated ES architec-
ture [17,24-30]. In trial-centered patient cohort identifi-
cation, a logic-based filter was applied first utilizing
demographics to exclude ineligible patients for a trial
(Step 1 in Figure 3). The diagnoses and clinical notes of
pre-filtered patients were then processed, from which
the medical terms were extracted and stored in the pa-
tient pattern vectors (Step 2). The same process wasapplied to the trial criteria to construct the trial pattern
vector (Step 3). Finally, the IE function computed the
degree of match between the patient vectors and the trial
pattern vector (Step 4) and output the ranked list of pa-
tients based on the matching scores (Step 5). Vice versa,
the ES algorithm also output a ranked list of trials for a
patient in patient-centered trial recommendation (Step 6).
Demographics-based filter
Since age and gender were retrieved from the eligibility
criteria (Figure 1), we adopted them as demographics-
based filters that have been proven to be beneficial by earl-
ier studies [24-26]. We also applied the trial enrollment
Figure 3 The architecture of the automated ES algorithm.
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did not have clinical notes within the enrollment window
of a trial (e.g. between the opening and the closing dates),
implying that patient was not participating in the care of
CCHMC physicians during the enrollment period, the
patient was ruled out for that particular trial.
Text and medical terms processing
The text and medical terms processing utilized advanced
NLP techniques to extract medically relevant informa-
tion from the patients’ clinical notes and the trial eligibil-
ity descriptions. Details of the NLP process can be found
in our earlier publications [17,32-35]. To summarize, the
algorithm first extracted text-driven, term-level medical
information (e.g. keywords and acronyms in Figure 1)
from clinical narratives using the Apache clinical Text
Analysis and Knowledge Extraction System (cTAKES)
[36]. cTAKES then assigned medical terms to the identi-
fied text strings from controlled terminologies, including
Concept Unique Identifiers (CUI) from the Universal
Medical Language System (UMLS), the Systematized No-
menclature of Medicine Clinical Terms codes (SNOMED-
CT), and a standardized nomenclature for clinical drugs
(RxNorm) [37-39]. The same process was applied to iden-
tify text and medical terms from the diagnosis strings. Inaddition, the ICD-9 codes were mapped to SNOMED-
CT terms using the UMLS ICD-9 to SNOMED-CT
dictionary [40].
To identify negations, we implemented a negation de-
tector based on the NegEx algorithm [41]. For example,
the phrase “No CSN disease” (Figure 1) was converted
to “NEG23853001”. The text and medical terms were
converted if necessary in the assertion detection compo-
nent. Finally, all identified text and medical terms were
stored as bag-of-words in a patient vector.
For the trial eligibility description, the same text and
medical term processing was applied to the inclusion
and exclusion criteria to extract term-level patterns. All
terms extracted from the exclusion criteria were con-
verted into negated format.
Trial-patient matching function
The text and medical terms extracted from a patient’s
EHR were stored in a vector to represent the patient’s
profile. The same process was executed to build the pat-
tern vector for a clinical trial. The IE function then
matched the trial and the patient vectors and computed
the matching score for each trial-patient pair [42]. Fi-
nally, a ranked list of patient candidates was returned for
a trial in trial-centered patient cohort identification and
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trial recommendation.
Experiments
We used two methods to evaluate the performance of
the ES algorithm. First, we evaluated the screening effi-
ciency in identifying all historical enrollment decisions
shown in Table 1A. We refer to this evaluation as retro-
spective workload evaluation. Second, an oncologist per-
formed a manual review of the algorithm's randomly
selected 76 trial-patient assignments. We refer to this
evaluation as physician chart review.
For comparison, we used the output of the
demographics-based filter, which has been implemented
in many EHR products, as the baseline. In trial-centered
patient cohort identification, the baseline excluded ineli-
gible patients by demographics and randomly shuffled the
rest of the candidates for a trial. Similarly, it excluded in-
eligible trials and randomly shuffled the pre-filtered trials
for a patient in patient-centered trial recommendation. The
baseline simulated the screening process without auto-
mated ES, replicating current practice. In addition, we vali-
dated the contributions of the structured diagnoses/ICD-9
codes and the unstructured clinical notes. That is, we used
the two data sets individually and in combination in the ES
algorithm and assessed the performance respectively.
Retrospective workload evaluation
To assess the screening efficiency of the algorithms, we cal-
culated the average workload of the recruitment process
[16]. In trial-centered patient cohort identification, theTable 1 The performance of the demographics-based filter (b
Trial-centered Patient Cohort Identification
Algorithm Evaluation Metrics
WL 95% CI P[%] Sp[%]
Demographics-based Filter 163 149-179 1.9 24.3
DX/ICD-9 50 35-64 6.20 78.1
NOTE 28 16-41 10.7 87.9
DX/ICD-9+NOTE 24 14-35 12.6 89.9
Patient-centered Trial Recommendation
Algorithm Evaluation Metrics
Sub-population case (127 patients)
WL 95% CI P[%] Sp[%]
Demographics-based Filter 42 40-43 3.2 25.5
DX/ICD-9 8 6-10 16.8 87.8
NOTE 4 3-5 33.1 95.0
DX/ICD-9+NOTE 3 3-4 35.7 95.5
DX/ICD9 indicates ES algorithm using only structured diagnoses and ICD-9 codes; N
both structured data and clinical notes.
WL indicates workload; CI, confidence interval; P, precision and Sp, specificity, PV, p
*P-values were calculated by comparing the workload between DX/ICD-9+NOTE wi
N/A indicates that the performances between the two algorithms are identical andworkload is defined as the number of patients an oncologist
would be required to review, from the population of 215
patients, to identify all patients historically enrolled in a
particular trial.
In patient-centered trial recommendation, the number of
trials an oncologist would need to review to replicate a pa-
tient’s historical trial enrollments defines the workload. For
this scenario, the algorithm was evaluated on the 127 pa-
tients who had historical enrollments. We refer to this re-
sult as sub-population case. In practice some patients (e.g.
patients who did not have historical enrollments) could be
ineligible for all clinical trials and an oncologist would have
to screen all available trials to confirm their ineligibity. To
assure the integrity of the evaluation, we also evaluated the
algorithms on all 215 patients, which we refer to as the full-
population case. Note that in this case, an oncologist would
have to review all algorithm output trials to confirm a pa-
tient’s ineligibility if the patient had no historical enroll-
ments (88 patients in the study).
In addition to the average workload, precision (denoted
by P) and specificity (denoted by Sp) were applied to
measure screening performance. Since the goal of the
retrospective workload evaluation was to identify all his-
torical enrollments (i.e. False Negative = 0), the recall =
True Positive/(True Positive + False Negative) and the
negative predictive value NPV = True Negative/(True
Negative + False Negative) were always 100%.
Physician chart review
An oncologist conducted a manual, retrospective, chart






Full-population case (215 patients)
PV* WL 95% CI P[%] Sp[%] PV*
1.7E-143 42 40-43 1.9 24.3 1.5E-39
2.36E-7 22 19-25 3.6 60.7 3.85E-7
2.54E-2 20 17-23 3.9 64.9 2.54E-2
N/A 19 17-22 4.0 65.5 N/A
OTE, ES algorithm using only clinical notes; DX/ICD-9+NOTE, ES algorithm using
-value.
th the other algorithms.
no p-value is returned.
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the historical enrollment decisions might have depended
on factors that were not included in the scope of this
study. For example, we did not try to detect the patients’
preferences for a particular cancer treatment, for out-
patient versus inpatient care, or for the route of adminis-
tration (e.g. pill versus infusion therapy). Our ES
algorithm might predict candidate trials for a patient
that the patient was truly eligible for, based on his/her
clinical information, but because of the patient’s prefer-
ence the physician did not enroll the patient in that trial.
Consequently, the retrospective workload evaluation
would report a lower algorithm precision than the true
measure would be based on the scope of our study. Add-
ing the manual retrospective chart review accounted for
the external factors (e.g. patient preferences described in
the clinical notes) and provided an adjustment for the
precision.
We reported the results of the physician chart review on
trial-centered patient cohort identification. Specifically, we
randomly sampled ten trials (20% of the trials) and
regarded the top 2 ×N candidates from the ES algorithm
as potentially eligible patients, where “N” denotes the
number of actually enrolled patients for a particular trial
at CCHMC (Table 1A). For instance, the NCT00134030
trial had nine historical enrollments and the ES algorithm
provided 18 patients as potentially most eligible candi-
dates for the trial. In the next step an oncologist with clin-
ical trial experience reviewed the clinical notes, which
were written during the study period, and determined
how many of the 18 patients were truly eligible for the
NCT00134030 trial. Finally, the precision of the ES algo-
rithm was re-calculated based on the results of the chartTable 2 The precision of the ES algorithm against the historic
the oncologist
NCT ID Number of historical








NCT00072384 1 2 1
NCT00134030 9 18 9
NCT00274937 1 2 1
NCT00335556 2 4 0
NCT00343694 3 6 1
NCT00379340 1 2 0
NCT00382109 2 4 0
NCT00553202 6 12 4
NCT00557193 1 2 1
NCT01190930 12 24 12
TOTAL 38 76 29
Precision N/A N/A 0.38
*Indicates that more patients in the algorithm output were eligible for this trial thareview. The physician chart review also contributed infor-
mation to our error analysis and identified limitations of
the automated ES algorithm.
Results
Retrospective workload evaluation
Table 1 shows the results of eligibility screening with the
baseline (demographics-based filter) and the EHR-based
ES algorithms. For trial-centered patient cohort identifi-
cation, an oncologist would need to review 163 patients
per trial using the baseline. Utilizing structured diagno-
ses/ICD-9 codes in the ES algorithm (DX/ICD-9), the
workload was reduced to 50 patients per trial. By lever-
aging both structured data and clinical notes, the ES algo-
rithm (DX/ICD-9 +NOTE) achieved the best workload
performance (24 patients per trial), amounting to an 85%
workload reduction over the baseline (p-value = 8.30E-21
in paired-T test).
In automated patient-centered trial recommendation,
we observed consistent improvement in workload when
more EHR data was used. Compared with the baseline,
the workload was reduced by more than 90% to 4 trials per
patient when the complete ES algorithm (DX/ICD-9 +
NOTE) was leveraged. Even for the full-population case,
the average workload of automated ES was statistically sig-
nificantly lower than the baseline (20 versus 42 trials per
patient, p-value = 1.5E-39 in paired-T test).
Physician chart review
Table 2 shows the findings of the physician chart review.
From the list of algorithm generated patient candidates
the oncologist found that 34 patients were truly eligible
for the ten randomly selected trials. On the other hand,al enrollments and the list of eligible patients found by
f historical
ts in the algorithm
Number of additional eligible patients found













n the number of historical enrollment decisions.
Table 3 The false positive errors made by the ES
algorithm with the causes described by the oncologist




Previously enrolled in the trial/therapy at a
different institution
3
New diagnosis treated with standard of
care therapy due to high likelihood of survival
4
Correct diagnosis but in a different stage
of the disease (e.g. high risk versus low risk)
5
Correct diagnosis but incorrect relapse status
(e.g. relapsed versus non-relapsed, remission
1 versus remission 2)
5
Wrong diagnosis, confusion between
sub-categories of diseases (e.g. ALL versus AML,
T cell versus Pre-B cell and different types of
renal tumors)
13
Wrong diagnosis, other reasons 12
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Consequently, the adjusted precision of the ES algorithm
increased to 0.45 on this randomly sampled trial-patient
set, amounting to an 18.4% relative improvement over
the 0.38 precision against the historical enrollment data.
Discussion
Performance analysis
Our results show that a fully-automated ES algorithm,
that relies on the narrative eligibility criteria of clinical
trials and the information from patient EHRs, could
achieve notable workload reduction in both trial-centered
patient cohort identification (85%) and patient-centered
trial recommendation (more than 90%) compared with
demographics-based screening (Table 1). The ES algo-
rithm showed good capability in matching the descriptive
criteria with patients’ clinical problems (DX/ICD-9 results
in Table 1). However, without the comprehensive informa-
tion from clinical notes (Figure 2), the algorithm would be
unable to achieve accurate trial-patient matching. Using
clinical notes (NOTE) greatly improved the matching
accuracy of the ES algorithm, which was evidenced by a
workload reduction of 44% over the DX/ICD-9 algorithm
in trial-centered patient cohort identification and 50% in
patient-centered trial recommendation. In addition, the
NOTE algorithm’s performance was close to the perform-
ance of the ES using both structured data and clinical
notes (DX/ICD-9 +NOTE). This is expected because the
patients’ diagnoses were also documented in the clinical
notes (e.g. History & Physical notes and discharge sum-
maries). Consequently, the structured diagnosis/ICD-9
data did not contribute substantially when clinical notes
were used. The observations validate the value of unstruc-
tured clinical notes in automated ES and confirm the
effectiveness of the NLP and IE techniques as previously
demonstrated by us and other groups [17,24,25,29].
Projecting the results of the physician chart review to
the entire data set, the performance of the automated ES
algorithm would be improved by 18.4% to 0.149 (preci-
sion) in trial-centered patient cohort identification. Fur-
ther refinements of the algorithm are required to
increase precision. However, even at this early stage of
development, automated ES provides a sufficiently high
yield of accurate screening hits to substantially improve
the oncologists’ efficiency in evaluating the patients’
eligibility for clinical trials.
Error analysis, limitations and future work
To describe the limitations of our ES algorithm, we
grouped the causes of the 42 oncologist-identified errors
into six categories (Table 3). The error analysis suggested
several areas for improvement. First, 54.7% of the errors
(categories 3–5) were caused because the algorithm con-
fused similar phrases (e.g. “T cell lymphoblasticlymphoma” versus “Pre-B cell lymphoblastic lymph-
oma”). The reason is that our algorithm used individual
words as patterns, limiting its ability in finding semantic
relations between consecutive words. In the future we
will integrate advanced NLP techniques to analyze se-
mantic relations to see if they improve the accuracy of
medical concept identification. Second, the algorithm
failed to distinguish the patients’ new and historical diag-
noses and caused an additional 10% of the errors (category
2). The observation validated the need for including tem-
poral reasoning in automated ES. Finally, the logic-based
filter was restricted to screening the demographics only,
which limited its ability in capturing certain exclusion cri-
teria (e.g., previous enrollment status, category 1). The al-
gorithm will be more powerful if more information from
the structured data fields (e.g. enrollment information,
vital signs and laboratory results) of the EHR are included.
The steps to extract this information from narrative eligi-
bility criteria to design a complex logic-based filter will
also be investigated in future works.
One limitation of our study is that the evaluation was
restricted to retrospective data. Project planning is in
progress to evaluate the practicality of the automated ES
in a randomized controlled prospective test environ-
ment. In addition, the study’s scope was restricted to
pediatric oncology clinical trials. Because of the almost
universal clinical trial enrollment in pediatric oncology,
it is possible that the patients’ notes include more infor-
mation to automate the ES than the adult oncology
patients’ notes would. To verify the transferability of the
findings, we also plan to test the ES algorithm on a more
diversified oncology patient population (e.g. adult pa-
tients) and include multiple institutions. Finally, the text
of the eligibility criteria in oncology trials is more
descriptive than in other subspecialties, providing a
potentially more suitable foundation for NLP and IE. If a
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olds, a different type or a hybrid approach involving
quantitative logic and NLP/IE may be more appropriate,
as we showed in an earlier study [17].Conclusion
By leveraging NLP and IE technologies on both the trial
criteria and the EHR content of the patients, an auto-
mated eligibility pre-screening algorithm could dramatic-
ally increase the trial screening efficiency of oncologists.
In a retrospective evaluation of real world data, the
algorithm achieved 85% workload reduction in trial-
centered patient cohort identification and more than
90% in patient-centered trial recommendation, while
keeping the precision at a manageable level (12.6% and
35.7% respectively). Consequently, we hypothesize that
the algorithm, when rolled out for production, will have
the potential to substantially reduce the time and effort
necessary to execute clinical research, particularly as
important new initiatives of the cancer care community
(e.g. the NCI National Clinical Trials Network) intend
to greatly expand both the access to trials and the num-
ber of available trials.
The study also demonstrated the usability of the physi-
cians’ historical enrollment decisions for evaluating auto-
mated ES algorithms. However, the results showed the
need for manual chart review to determine the true level
of algorithm precision when such evaluation is conducted.Additional file
Additional file 1: Table S1. The list of clinical trials and the
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